Literature DB >> 17703249

Helicobacter pylori infection in Ontario: prevalence and risk factors.

Farah Naja1, Nancy Kreiger, Terrence Sullivan.   

Abstract

BACKGROUND: Helicobacter pylori has been classified by the World Health Organization as a type I carcinogen. Nearly 50% of the world's population is estimated to be infected with H pylori. Prevalence patterns of the infection are different between developing and developed countries. The present study had two objectives - to estimate the prevalence of H pylori infection in Ontario, and to evaluate the relationship between the infection and various demographic characteristics and selected lifestyle factors.
METHODS: Ten microlitres of plasma were aliquoted from stored blood of 1306 men and women, 50 to 80 years of age, from Ontario. The blood samples belonged to control patients of a colorectal cancer population-based study group. Serological testing was used to detect H pylori infection; information was obtained on dietary intake and lifestyle habits, as well as past and present medical history, education, income, number of siblings, ethnicity and place of birth.
RESULTS: The overall weighted seroprevalence of H pylori was 23.1% (95% CI 17.7% to 29.5%), with men having higher infection rates (29.4%, 95% CI 21.1% to 39.3%) than women (14.9%, 95% CI 10.1% to 21.4%). Seroprevalence of the infection increased significantly with age and number of siblings. Increased risk was also associated with being nonwhite, being born outside of Canada and immigrating at 20 years of age or older. An inverse association with seroprevalence was found for education and alcohol consumption.
CONCLUSION: The prevalence of H pylori infection in Ontario is comparable with that of other developed countries. Age, sex, number of siblings, ethnicity, place of birth and age at immigration are among the factors associated with H pylori infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17703249      PMCID: PMC2657974          DOI: 10.1155/2007/462804

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


  36 in total

1.  Seroprevalence of helicobacter pylori infection in couples.

Authors:  G I Perez-Perez; S S Witkin; M D Decker; M J Blaser
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

2.  A population-based serologic survey of Helicobacter pylori infection in children and adolescents in the United States.

Authors:  M A Staat; D Kruszon-Moran; G M McQuillan; R A Kaslow
Journal:  J Infect Dis       Date:  1996-11       Impact factor: 5.226

3.  Seroprevalence of Helicobacter pylori in a birth cohort of 21-year-old New Zealanders.

Authors:  J P Fawcett; J P Shaw; M Cockburn; M Brooke; G O Barbezat
Journal:  Eur J Gastroenterol Hepatol       Date:  1996-04       Impact factor: 2.566

4.  Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status.

Authors:  D Y Graham; H M Malaty; D G Evans; D J Evans; P D Klein; E Adam
Journal:  Gastroenterology       Date:  1991-06       Impact factor: 22.682

5.  Rate of Helicobacter pylori acquisition among Finnish adults: a fifteen year follow-up.

Authors:  P Sipponen; T U Kosunen; I M Samloff; O P Heinonen; M Siurala
Journal:  Scand J Gastroenterol       Date:  1996-03       Impact factor: 2.423

6.  Biologic sex as a risk factor for Helicobacter pylori infection in healthy young adults.

Authors:  M L Replogle; S L Glaser; R A Hiatt; J Parsonnet
Journal:  Am J Epidemiol       Date:  1995-10-15       Impact factor: 4.897

7.  [Antibiotic consumption in relation to sex and age].

Authors:  N Luknárová; M Slezáková; A Blahútová
Journal:  Cesk Farm       Date:  1992-07

8.  Wine as a digestive aid: comparative antimicrobial effects of bismuth salicylate and red and white wine.

Authors:  M E Weisse; B Eberly; D A Person
Journal:  BMJ       Date:  1995 Dec 23-30

Review 9.  The prevalence of Helicobacter pylori infection in different countries.

Authors:  R E Pounder; D Ng
Journal:  Aliment Pharmacol Ther       Date:  1995       Impact factor: 8.171

10.  Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials.

Authors:  J Parsonnet; R A Harris; H M Hack; D K Owens
Journal:  Lancet       Date:  1996-07-20       Impact factor: 79.321

View more
  27 in total

Review 1.  Helicobacter pylori in First Nations and recent immigrant populations in Canada.

Authors:  Nicola Jones; Naoki Chiba; Carlo Fallone; Alan Thompson; Richard Hunt; Kevan Jacobson; Karen Goodman
Journal:  Can J Gastroenterol       Date:  2012-02       Impact factor: 3.522

2.  ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.

Authors:  William D Chey; Grigorios I Leontiadis; Colin W Howden; Steven F Moss
Journal:  Am J Gastroenterol       Date:  2017-01-10       Impact factor: 10.864

3.  On the association between soft drink consumption and Helicobacter pylori infection.

Authors:  W Nseir; J Mograbi; N Di Castro; O Abu-Elheja; Z Abu-Rahmeh; I Khamaysi; M Samara; N Assy
Journal:  Dig Dis Sci       Date:  2011-11-05       Impact factor: 3.199

Review 4.  Is There a Link Between H. Pylori and the Epidemiology of Crohn's Disease?

Authors:  Ayesha Shah; Nicholas J Talley; Marjorie Walker; Natasha Koloski; Mark Morrison; Daniel Burger; Jane M Andrews; Michael McGuckin; Mike Jones; Gerald Holtmann
Journal:  Dig Dis Sci       Date:  2017-03-09       Impact factor: 3.199

Review 5.  Prophylactic use of aspirin: systematic review of harms and approaches to mitigation in the general population.

Authors:  Mangesh A Thorat; Jack Cuzick
Journal:  Eur J Epidemiol       Date:  2014-11-25       Impact factor: 8.082

6.  Seroprevalence of anti-Hp and anti-cagA antibodies among healthy persons in Golestan province, northeast of Iran (2010).

Authors:  Fatemeh Ghasemi Kebria; Haniye Bagheri; Shahryar Semnani; Ezatollah Ghaemi
Journal:  Caspian J Intern Med       Date:  2011

7.  Prevalence of Helicobacter pylori in a First Nations population in northwestern Ontario.

Authors:  Abhimanyu Sethi; Monica Chaudhuri; Len Kelly; Wilma Hopman
Journal:  Can Fam Physician       Date:  2013-04       Impact factor: 3.275

8.  Helicobacter pylori status among patients undergoing gastroscopy in rural northern Alberta.

Authors:  Isabelle N Colmers-Gray; Ben Vandermeer; Robert I Greidanus; Michael R Kolber
Journal:  Can Fam Physician       Date:  2016-09       Impact factor: 3.275

9.  Helicobacter pylori infection and Hyperemesis gravidarum. An institution-based case-control study.

Authors:  Irene Sandven; Michael Abdelnoor; Marianne Wethe; Britt-Ingjerd Nesheim; Ase Vikanes; Halvard Gjønnes; Kjetil K Melby
Journal:  Eur J Epidemiol       Date:  2008-05-21       Impact factor: 8.082

10.  Germline variants and phenotypic spectrum in a Canadian cohort of individuals with diffuse gastric cancer.

Authors:  M Aronson; C Swallow; A Govindarajan; K Semotiuk; Z Cohen; P Kaurah; L Velsher; I Ambus; K Buckley; C Forster-Gibson; W S Meschino; A Blumenthal; R H Kim; S Brar
Journal:  Curr Oncol       Date:  2020-05-01       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.